Phytolacca acinosa
What's the taxonomical classification of Phytolacca acinosa?
Phytolacca acinosa belongs to the kingdom Plantae and is categorized under the phylum Streptophyta. Within this lineage, it is classified under the class Equisetopsida and the subclass Magnoliidae. Following the order Caryophyllales, the plant is placed in the family Phytolaccaceae. Its specific taxonomic hierarchy is completed by its assignment to the genus Phytolacca, ultimately identifying it as the species Phytolacca acinosa.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Phytolaccaceae |
| Genus | Phytolacca |
| Species | acinosa |
What are the morphological characteristics of this plant?
Phytolacca acinosa has an erect, perennial herbaceous habit characterized by smooth, fleshy stems that can reach heights of up to two meters. The leaves are alternate, lanceolate to ovate in shape, and possess entire margins with prominent venation. Large, terminal panicles of small, greenish-white flowers emerge from the upper nodes to facilitate pollination. These inflorescences eventually develop into dense, fleshy clusters of dark purple to blackish berries. The root system typically consists of a thick, somewhat fleshy taproot that anchors the plant firmly in the soil.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical regions of South and Southeast Asia, specifically spanning from India and Sri Lanka through China and into parts of Southeast Asia. It thrives primarily in warm, humid climates where seasonal rainfall is abundant. Its distribution is often concentrated in disturbed areas, forest edges, and along riverbanks throughout these Asian territories. Because it is a resilient species, it has occasionally been documented in other tropical zones beyond its original range. The presence of the species is closely tied to specific soil moisture levels found in these regional habitats.
How is this plant cultivated?
This plant Phytolacca acinosa thrives in moist, well-drained soil within subtropical or tropical climates that maintain consistent humidity.
Growers should plant it in partial shade to prevent the leaves from scorching under intense direct sunlight. Regular watering is essential to keep the substrate damp, though the root system can tolerate brief periods of dryness once established. It requires nutrient-rich organic matter to support its vigorous growth and the production of characteristic dark berries.
Careful monitoring is necessary because the plant can become invasive in certain environments if left unmanaged.
What parts of this plant are used medicinally?
This plant Phytolacca acinosa is utilized medicinally through its berries, fruit, root, seed, and flower. The tuberous root is the most frequently employed part for treating skin conditions and internal ailments. Both the seeds and the fruit contain potent compounds that are carefully processed for therapeutic applications. The berries are often used in traditional preparations due to their specific chemical properties. Additionally, extracts from the flower are sometimes incorporated into specialized medicinal formulas.
According to a study published by "Journal of natural products", three new triterpenoids named acinospesigenin-A (1), -B (2), and -C (3) were isolated from the berries of Phytolacca acinosa. These compounds are characterized as 3 beta-acetoxy-11 alpha,23-dihydroxytaraxer-14-en-28-oic acid, olean-12-en-23-al-2 beta,3 beta-dihydroxy-30-methoxycarbonyl-28-oic acid, and olean-12-en-23-al-2 beta,3 beta,11 alpha-trihydroxy-30-methoxycarbonyl-28-oic acid. The identified substances have demonstrated antiedemic activity in albino rats. This specific activity was measured with an LD(50) of 10-15 mg/kg mass.
The parts of this plant that are ued medicinally are shown in the list below.
- berries
- fruit
- root
- seed
- flower
What traditional systems uses this plant?
This plant, known as pokeweed, has been utilized in Native American herbal medicine for centuries to treat a variety of ailments including skin conditions, swellings, and respiratory issues. Various tribes used decoctions of the roots or leaves as topical applications to soothe inflammation and manage wounds. Beyond medicinal uses, the plant served practical roles in traditional diets and as a source of pigment for ceremonial purposes. Indigenous healers often applied these botanical preparations with careful attention to dosage due to the plant's potent chemical properties. This historical reliance highlights the complex relationship between local ecosystems and ancestral wellness practices.
According to a study published by "Journal of ethnopharmacology", Phytolacca acinosa Roxb. (PAR) is a Traditional Chinese Medicinal (TCM) plant with a broad global distribution encompassing 35 species, including 4 found in the People's Republic of China. It occupies a significant role in both Oriental and American traditional medicine, where it is employed to treat conditions such as edema, inflammation, dermatitis, and rheumatism. The plant is documented in the Chinese Pharmacopoeia and has a longstanding history in TCM, specifically for its diuretic properties and in treating ailments such as swelling and ulcers. Additionally, PAR is utilized as a molluscicide and for addressing bronchitis and tumors.
The hystorical systems that uses this plant are shown in the list below.
- Native American Herbal Medicine
What are the pharmacological activities of Phytolacca acinosa?
This plant has anti-tumor, antibacterial, antiviral, anti-inflammatory, and antimicrobial pharmacological activities. Its bioactive compounds work to inhibit the growth of various pathogenic bacteria and viruses. Researchers have also documented its ability to combat infectious microorganisms through its potent antimicrobial properties. Additionally, the plant contains substances that effectively reduce swelling and pain via anti-inflammatory mechanisms. Studies further suggest that certain extracts possess significant anti-tumor potential by targeting malignant cell lines.
According to a study published by "Journal of ethnopharmacology", Phytolacca acinosa Roxb. (PAR) is a traditional medicinal plant used to treat conditions such as edema, inflammation, dermatitis, rheumatism, tumors, bronchitis, and swelling. The plant has demonstrated potent inhibitory effects against the A549 human lung cancer cell line. Through network pharmacology, xanthomicrol was identified as the foremost active compound in PAR. This component exhibits substantial impact on the proliferation and apoptosis of HepG2 and HCCLM3 cells. Furthermore, xanthomicrol targets the PI3K/Akt/MMP9 pathway and shows high affinity towards TNF, MMP9, PPARG, KDR, and MMP2.
The primary pharmacological activities of this plant are shown in the list below.
- anti-infective
- anti-tumor
- antimicrobial
- antiproliferative
- tumor-suppressive
What medicinal compounds this plant contains?
This plant contains medicinal compounds including Phytolacca acinosa polysaccharides I, acinospesigenin-A, acinospesigenin-B, acinospesigenin-C, and phytolacacinoside A. These specific phytochemicals are primarily concentrated within the roots and stems of the species. The presence of acinospesigenin derivatives suggests significant potential for pharmacological investigation. Additionally, the polysaccharides and phytolacacinoside A contribute to the plant's complex chemical profile. Researchers study these bioactive molecules to understand their diverse biological activities.
According to a study published by "Zhongguo yao li xue bao = Acta pharmacologica Sinica", Phytolacca acinosa polysaccharides I (PEP-I) was administered at doses of 80 and 160 mg/kg ip twice every 4 d. Both PEP-I doses demonstrated significant enhancing activity on macrophage cytotoxicity against S180 sarcoma cells and malignant transformed fibroblast L929 cells. Peritoneal activated macrophages were incubated with LPS for 2 and 24 h to induce TNF and IL-1. The optimal time for TNF production was found on d 8, where significant increases in TNF and IL-1 were observed. While there was no difference between the effect of PEP-I on TNF compared to the priming agent BCG, PEP-I showed a high effect on IL-1.
The primary medicinal compounds of this plant are shown in the list below.
- Phytolacca acinosa polysaccharides I
- acinospesigenin-A
- acinospesigenin-B
- acinospesigenin-C
- phytolacacinoside A
What health conditions is this plant used for?
This plant is used for treating S180 sarcoma, hepatocellular carcinoma, lung cancer, and various other types of cancer or tumors. Research into its bioactive compounds suggests potential therapeutic applications in oncology. Scientists study its ability to inhibit the growth of malignant cells in laboratory settings. These investigations focus on how the plant might combat aggressive forms of cancer like lung cancer and hepatocellular carcinoma. The medicinal properties of Phytolacca acinosa remain a significant subject of interest for developing new anticancer treatments.
According to a study published by "Zhongguo yao li xue bao = Acta pharmacologica Sinica", Phytolacca acinosa polysaccharides I (PEP-I) was studied for its effects on the immunologic cytotoxicity of mouse peritoneal macrophages and its production of tumor necrosis factor (TNF) and interleukin 1 (IL-1). Dosages of PEP-I at 80 and 160 mg/kg were administered ip twice every 4 d. Both doses showed significant enhancing activity on macrophage cytotoxicity against S180 sarcoma cells and malignant transformed fibroblast L929 cells. Following incubation with LPS for 2 and 24 h to induce TNF and IL-1, the optimal time for TNF production was found on d 8. Significant increases in TNF and IL-1 were observed, with PEP-I showing a high effect on IL-1 compared to the priming agent BCG.
The main health conditions this plant is used for are shown in the list below.
- S180 sarcoma
- cancer
- hepatocellular carcinoma
- lung cancer
- tumor
What are the herbal preparations of this plant?
This plant is Phytolacca acinosa, a species used to create medicinal herbal preparations such as Phytolaccae Radix ethanol extract for various therapeutic applications. The root of this plant serves as the primary source for extracting bioactive compounds through alcohol-based processes. These preparations are often utilized in traditional medicine to address inflammatory conditions and certain types of growths. Due to the presence of potent saponins, careful dosage and standardization are essential to ensure patient safety. Practitioners must handle these extracts with precision to harness their biological activity effectively.
The main herbal preparations of this plant are shown in the list below.
- Phytolaccae Radix ethanol extract
What side effects this plant can have?
This plant can cause severe health side effects including nausea, vomiting, diarrhea, abdominal pain, inflammation of mucous membranes, skin irritation, dizziness, convulsions, and respiratory distress. Ingesting even small amounts of its toxic components often leads to acute gastrointestinal distress such as intense vomiting and painful abdominal cramping. Contact with the plant's sap frequently results in localized skin irritation or the inflammation of sensitive mucous membranes. Systemic toxicity can progress to neurological symptoms like dizziness and violent convulsions. In extreme cases, the toxins may cause life-threatening respiratory distress in affected individuals.
The main side effects this plant can have are shown in the list below.
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Inflammation of mucous membranes
- Skin irritation
- Dizziness
- Convulsions
- Respiratory distress
What herbs are paired with Phytolacca acinosa?
This plant Phytolacca acinosa is most commonly paired with cleansing herbs like sapindus saponaria or bitter tonics such as artemisia annua to balance its potent properties.
These combinations are often used in traditional topical applications to enhance skin detoxification. Pairing it with soothing agents like aloe vera can also help mitigate potential irritation from its bioactive compounds. Herbalists frequently experiment with these blends to optimize the plant's emetic or purgative effects.
Careful consideration of these synergies is essential due to the plant's inherent toxicity.